ADAM8
Basic information
Region (hg38): 10:133262420-133276868
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (165 variants)
- not_provided (10 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAM8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001109.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 18 | ||||
| missense | 138 | 21 | 162 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 0 | 0 | 140 | 38 | 4 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ADAM8 | protein_coding | protein_coding | ENST00000445355 | 23 | 14466 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.20e-14 | 0.821 | 124578 | 4 | 897 | 125479 | 0.00360 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.380 | 467 | 491 | 0.952 | 0.0000326 | 5210 |
| Missense in Polyphen | 186 | 192.94 | 0.96401 | 2104 | ||
| Synonymous | -1.26 | 241 | 217 | 1.11 | 0.0000162 | 1670 |
| Loss of Function | 1.94 | 28 | 41.5 | 0.675 | 0.00000204 | 472 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00377 | 0.00375 |
| Ashkenazi Jewish | 0.0152 | 0.0145 |
| East Asian | 0.00709 | 0.00699 |
| Finnish | 0.000707 | 0.000693 |
| European (Non-Finnish) | 0.00394 | 0.00385 |
| Middle Eastern | 0.00709 | 0.00699 |
| South Asian | 0.00135 | 0.00131 |
| Other | 0.00585 | 0.00573 |
dbNSFP
Source:
- Function
- FUNCTION: Possible involvement in extravasation of leukocytes.;
- Pathway
- Neutrophil degranulation;Extracellular matrix organization;Innate Immune System;Immune System;Degradation of the extracellular matrix;Alpha9 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.143
Haploinsufficiency Scores
- pHI
- 0.354
- hipred
- N
- hipred_score
- 0.172
- ghis
- 0.474
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adam8
- Phenotype
- normal phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- adam8a
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- increased accumulation
Gene ontology
- Biological process
- cell morphogenesis;angiogenesis;leukocyte migration involved in inflammatory response;positive regulation of acute inflammatory response;proteolysis;inflammatory response;positive regulation of protein processing;regulation of cell-cell adhesion;extracellular matrix disassembly;positive regulation of T cell differentiation in thymus;neutrophil degranulation;positive regulation of MAP kinase activity;negative regulation of neuron apoptotic process;positive regulation of innate immune response;positive regulation of bone resorption;positive regulation of cell adhesion;lymphocyte chemotaxis;positive regulation of protein secretion;positive regulation of membrane protein ectodomain proteolysis;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase B signaling;positive regulation of thymocyte apoptotic process;cellular response to hypoxia;cell-cell adhesion;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;positive regulation of neutrophil extravasation;positive regulation of fibronectin-dependent thymocyte migration;positive regulation of eosinophil migration
- Cellular component
- podosome;cytoplasm;plasma membrane;integral component of plasma membrane;cell surface;phagolysosome;dense core granule membrane;specific granule membrane;specific granule;tertiary granule;tertiary granule membrane;alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;alpha9-beta1 integrin-ADAM8 complex;ficolin-1-rich granule membrane
- Molecular function
- metalloendopeptidase activity;serine-type endopeptidase activity;calcium ion binding;protein binding;metallopeptidase activity;zinc ion binding;protein self-association;cell adhesion molecule binding